Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...
Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.
Rapid delivery of new features positions Weaviate at the forefront of a booming market driven by enterprise adoption of ...
Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...
To thrive beyond rare disease, cell and gene therapy developers must scale-up manufacturing and commercialisation.
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...
IonQ moves ahead of QBTS and RGTI in 2026 with higher gate fidelity, faster execution and stronger revenue momentum, though ...
News-Medical.Net on MSN
Purdue-developed LENN system enhances stability and targeting of mRNA cancer therapies
Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...
Companies investing in unified, managed and rich data layers will drive innovation in the coming decade. Through these ...
The phishing campaign shows how attackers continue to weaponize legitimate cloud services and open source tools to evade ...
Microsoft’s investigation into RedVDS services and infrastructure uncovered a global network of disparate cybercriminals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback